Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...

A new way to quickly detect depression is causing a literal spit take. Trusting a depressed brain to self-diagnose is like asking a broken GPS if you’re lost. While it might seem obvious, depression ...

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

The FDA has expanded clearance for an accelerated treatment protocol for the noninvasive Deep Transcranial Magnetic Stimulation (Deep TMS, BrainsWay) system for depressive episodes and anxiety ...

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies that included 3,532 ...

A psychiatrist says one common blood test may reveal whether inflammation is playing a role in depression—and what you can do ...

A quick video game could help reveal signs that you have a major disorder, according to a new study. The diagnostic tool, which takes the form of a video game, measures whether the subject has ...